Lanao, Estrella A.

HRN: 13-55-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/08/2026
04/14/2026
IV
500mg
Q8
T/c Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines